Gene therapy trial offers hope for rare blindness condition
NCT ID NCT05926583
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 35 times
Summary
This study tests a gene therapy for Japanese people with X-linked retinitis pigmentosa, an inherited eye disease that causes vision loss. The treatment uses a harmless virus to deliver a working gene to the retina. The main goal is to check safety, with a secondary focus on whether it improves vision in low light after one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Hospital Organization Tokyo Medical Center
Meguro-ku, 1528902, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.